aspartic acid has been researched along with Coxsackie Virus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Gu, J; Huang, C; Kong, Q; Lin, D; Lu, R; Wu, W | 1 |
Berkley, N; Huber, S; Jeon, ES; Knowlton, KU; Wessely, R | 1 |
2 other study(ies) available for aspartic acid and Coxsackie Virus Infections
Article | Year |
---|---|
NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.
Topics: Alanine; Animals; Aspartic Acid; Biomarkers; Cardiomyopathy, Dilated; Coxsackievirus Infections; Enterovirus B, Human; Glutamic Acid; Glutamine; Glycine; Mice; Mice, Inbred BALB C; Myocarditis; Niacin; Niacinamide; Serine; Taurine; Threonine | 2022 |
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Topics: Animals; Aspartic Acid; Base Sequence; Capsid; Capsid Proteins; Cloning, Molecular; COS Cells; Coxsackievirus Infections; DNA, Complementary; DNA, Viral; Enterovirus B, Human; Genetic Variation; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation; Myocarditis; Phenotype | 1996 |